Learn how to calculate cjc 1295 dac 10mg dosage for research, including reconstitution, typical protocols, and safety notes. For research use only.
The typical research dosage for a 10mg vial of CJC-1295 DAC is 1 to 2 mg per week, often given as a single weekly injection or split into two doses. This peptide is not FDA-approved for human use, and all dosage information is intended for laboratory research only. Always consult a healthcare professional before considering any peptide.
What Is CJC-1295 DAC?
CJC-1295 DAC is a long-acting growth hormone-releasing hormone (GHRH) analog. The "DAC" stands for Drug Affinity Complex, which binds to albumin in the blood and extends the peptide's half-life to several days. This is different from CJC-1295 No DAC, which has a much shorter half-life of about 30 minutes.
Researchers use CJC-1295 DAC to study growth hormone secretion and related pathways. It is sold as a lyophilized powder in vials, and 10mg is a common size. The powder must be reconstituted with bacteriostatic water before use.
| Feature | CJC-1295 DAC | CJC-1295 No DAC |
|---|---|---|
| Half-life | ~6-8 days | ~30 minutes |
| Dosing frequency | 1-2 times per week | 1-3 times daily |
| Typical research dosage | 1-2 mg per week | 100-300 mcg per dose |
| FDA approval | Not approved | Not approved |
How to Calculate CJC-1295 DAC 10mg Dosage After Reconstitution
To calculate your dosage, you first need to know the concentration of the reconstituted solution. The concentration depends on how much bacteriostatic water you add to the 10mg vial. More water means a lower concentration per milliliter.
For example, if you add 2 mL of bacteriostatic water to a 10mg vial, the concentration is 5 mg/mL. A 1 mg dose would be 0.2 mL, which is 20 units on a U-100 insulin syringe. A 2 mg dose would be 0.4 mL, or 40 units.
| BAC Water Added | Concentration | 1 mg Dose (units) | 2 mg Dose (units) |
|---|---|---|---|
| 1 mL | 10 mg/mL | 10 units | 20 units |
| 2 mL | 5 mg/mL | 20 units | 40 units |
| 2.5 mL | 4 mg/mL | 25 units | 50 units |
| 5 mL | 2 mg/mL | 50 units | 100 units |
Many researchers prefer 2 mL of water for a 10mg vial because it gives a convenient concentration for measuring both 1 mg and 2 mg doses. A cjc-1295 dac 10mg vial is a common size, and accurate reconstitution is critical for reproducible results.
Common Research Protocols for CJC-1295 DAC
Research protocols for CJC-1295 DAC vary widely. Some studies use a single weekly injection of 1 mg, while others use 2 mg once per week or 1 mg twice per week. The choice depends on the study's goals and the researcher's experience.
When researchers discuss the cjc-1295 with dac dosage, they often reference a weekly injection of 1–2 mg. Because of the long half-life, frequent dosing is not necessary and may increase the risk of side effects in research animals.
Some protocols combine CJC-1295 DAC with other peptides like ipamorelin. For combination studies, the cjc-1295/ipamorelin 10mg dosage may involve a different ratio of peptides. Blends are available that contain both peptides in one vial, and the dosage is calculated based on the total peptide content.
Comparing CJC-1295 DAC with Other Peptide Options
CJC-1295 DAC is often compared with CJC-1295 No DAC, ipamorelin, and blends. Each has different half-lives, dosing frequencies, and research applications.
| Peptide | Half-Life | Typical Research Dosage | Frequency |
|---|---|---|---|
| CJC-1295 DAC | 6-8 days | 1-2 mg per week | 1-2x weekly |
| CJC-1295 No DAC | ~30 minutes | 100-300 mcg per dose | 1-3x daily |
| Ipamorelin | ~2 hours | 100-300 mcg per dose | 1-3x daily |
| CJC-1295 No DAC + Ipamorelin Blend | Varies | 100-300 mcg per dose | 1-3x daily |
Some blend products list a cjc 1295 ipamorelin 10mg dosage that combines both peptides in a single vial. For example, a 10mg blend might contain 5mg CJC-1295 No DAC and 5mg ipamorelin. The dosage is typically calculated based on the total peptide concentration, but researchers should verify the exact ratio from the supplier's certificate of analysis.
Researchers often review the cjc-1295 no dac ipamorelin 10mg blend dosage when designing combination studies. That blend is different from CJC-1295 DAC because the No DAC version clears the body much faster.
Safety, Side Effects, and Legal Status
CJC-1295 DAC is not approved by the FDA for human use. It is sold for research purposes only. Researchers must follow institutional guidelines and handle all peptides with appropriate safety precautions.
In research settings, potential side effects observed with GHRH analogs include injection site reactions, flushing, headache, and changes in blood sugar. Long-term effects are not well understood. Anyone considering peptide use should consult a healthcare professional.
Legal status varies by country. In the United States, CJC-1295 DAC is not a controlled substance, but it is not approved for human consumption. Purchasing it for personal use is a legal gray area, and quality can vary between suppliers.
Frequently Asked Questions
What is the typical CJC-1295 DAC 10mg dosage?
In research settings, a common dosage is 1 to 2 mg per week, often given as one or two injections. A 10mg vial can last several weeks at this dosage. CJC-1295 DAC is not FDA-approved for human use.
How much bacteriostatic water should I add to a 10mg vial of CJC-1295 DAC?
Most researchers add 2 mL of bacteriostatic water to a 10mg vial, yielding a concentration of 5 mg/mL. This makes it easy to measure 1 mg (20 units) or 2 mg (40 units) on a U-100 insulin syringe. The exact volume depends on your desired concentration.
Is CJC-1295 DAC the same as CJC-1295 No DAC?
No. CJC-1295 DAC has a Drug Affinity Complex that extends its half-life to about 6–8 days, so it is dosed 1–2 times per week. CJC-1295 No DAC has a half-life of about 30 minutes and is typically dosed 1–3 times daily. They are not interchangeable.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.